Crystalline salts of a potent HCV inhibitor

Details for Australian Patent Application No. 2011224311 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Yang, Bing-Shiou; Yip, Ka

Agent Spruson & Ferguson

Pub. Number AU-A-2011224311

PCT Pub. Number WO2011/112761

Priority 61/312,791 11.03.10 US

Filing date 10 March 2011

Wipo publication date 15 September 2011

International Classifications

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 - not condensed and containing further heterocyclic rings

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/112761 Priority application(s): WO2011/112761

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224313-Fiber optic cassette

2011224299-Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof